Chemotherapy and radiation before surgery for arm or leg sarcoma
Part of Cancer clinical trials.
This trial tests giving chemotherapy and radiation therapy together before surgery for soft tissue sarcoma in the arms or legs. The goal is to see if this approach can improve outcomes for people with larger, high-grade, or deep tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have soft tissue sarcoma in an arm or leg that is high-grade, at least 5 cm in size, or deep.
- You are between 18 and 75 years old.
- You are able to walk and take care of yourself (ECOG score 0-2).
- You have not had chemotherapy before.
- You have not had radiation therapy to the same area in the past.
- The sarcoma has not spread to lymph nodes or other parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment plan where you first get a shorter (hypofractionated) course of radiation and then have surgery to remove the tumor. It may help control the cancer locally in certain soft tissue sarcomas and improve surgical outcomes.
This trial tests combining anlotinib (a targeted therapy), doxorubicin (chemotherapy), and radiation given before surgery to shrink high-grade soft tissue sarcomas. The goal is to make the tumor easier to remove and improve outcomes.
This trial tests a step-by-step (sequential) chemotherapy plan given before surgery for adults with specific types of soft tissue sarcoma. The goal is to shrink or control the tumor before the operation and see how well this approach works and is tolerated.
This trial tests a shorter course of radiation given before surgery for soft tissue sarcoma in the arms, legs, or trunk wall. It aims to see if this approach works well long-term and may help you keep your limb.
This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.
This trial tests whether adding immunotherapy drugs (anlotinib and penpulimab) to radiation before surgery can help treat soft tissue sarcoma—a type of cancer in muscles, fat, or connective tissue. The goal is to shrink the tumor and improve surgical outcomes.
Hear when a new Soft Tissue Sarcomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.